- Home
- MTSI vs ICLR Comparison
MTSI vs ICLR Comparison
Compare MTSI & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MTSI | ICLR |
|---|---|---|
| Founded | 1950 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.8B | 14.3B |
| IPO Year | 2012 | 1998 |
Fundamental Metrics
Financial Performance| Metric | MTSI | ICLR |
|---|---|---|
| Price | $177.25 | $186.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 14 |
| Target Price | $171.43 | ★ $201.23 |
| AVG Volume (30 Days) | ★ 1.1M | 1.0M |
| Earning Date | 11-06-2025 | 10-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 7.47 |
| Revenue | $967,258,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $18.17 | N/A |
| Revenue Next Year | $12.69 | $0.76 |
| P/E Ratio | ★ N/A | $24.96 |
| Revenue Growth | ★ 32.58 | N/A |
| 52 Week Low | $84.00 | $125.10 |
| 52 Week High | $190.95 | $228.29 |
Technical Indicators
Market Signals| Indicator | MTSI | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 55.43 | 59.73 |
| Support Level | $183.52 | $178.80 |
| Resistance Level | $190.21 | $188.99 |
| Average True Range (ATR) | 7.07 | 7.59 |
| MACD | -0.04 | 1.34 |
| Stochastic Oscillator | 58.41 | 83.07 |
Price Performance
Historical ComparisonAbout MTSI MACOM Technology Solutions Holdings Inc.
MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.